Innovating.works Conecta tu I+D

Showing 1 to 20 of 40 results

ASAAP-plus: Clinical evaluation of AntimalarialS tri-therapy with AtovAquone-Proguanil for treatment of uncompli... BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2023-01 Susceptibility to Artemisinin-based combination therapies (ACTs) currently remains high among the African Plasmodium falciparum population,...
2024-03-11 - 2025-12-31 | Financiado

MARVAX: Development of novel viral vectored vaccines against Marburgviruses inducing robust and cross-reacti... BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 The frequency, magnitude, and geographical range of Marburg virus disease outbreaks are expanding, with recent cases emerging in Equatorial...
2023-11-23 - 2027-11-30 | Financiado

eWHORM: Enabling the WHO-Roadmap 2030 BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 We will establish for the first time in NTDs an adaptive clinical trial platform and improve clinical research infrastructure in four SSA co...
2023-03-02 - 2028-03-31 | Financiado

MOBILISE: MOBILISE: A novel and green mobile One Health laboratory for (re-)emerging infectious disease outbre... BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN tramitó un HORIZON EUROPE: HORIZON-CL3-2021-DRS-01 "Mobile laboratories are becoming increasingly important for quick response to epidemic outbreaks in remote areas. Due to climate change and...
2022-10-01 - 2025-09-30 | Financiado

ISIDORe: Integrated Services for Infectious Disease Outbreak Research BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN participó en un HORIZON EUROPE: HORIZON-INFRA-2021-EMERGENCY-02 The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest...
2022-02-09 - 2025-07-31 | Financiado

EPIC-CROWN-2: Equine Polyclonal antibodies Immunotherapy against COVID-19/SARS-CoV2–VOC BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN participó en un HORIZON EUROPE: HORIZON-HLTH-2021-CORONA-01 "The highly contagious SARS-CoV-2 virus has generated an unprecedented pandemic with global dramatic public health and socio-economic conseq...
2021-11-11 - 2023-11-30 | Financiado

MALART: Cellular basis of Artemisinin resistance in malaria parasites BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN tramitó un H2020: ERC-2020-ADG Blood stages of the protozoan parasite Plasmodium falciparum are responsible for malaria, a disease that kills more than 400'000 people annu...
2021-08-26 - 2026-11-30 | Financiado

EVA-GLOBAL: European Virus Archive GLOBAL BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN participó en un H2020: H2020-INFRAIA-2018-2020 EVA-GLOBAL gathers 38 academic institutions at the forefront of human, animal and plant research in Virology, associated with key Non-Govern...
2019-12-16 - 2024-09-30 | Financiado

ISOLDA: Improved Vaccination Strategies for Older Adults BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN participó en un H2020: H2020-SC1-BHC-2018-2020 ISOLDA aims at the development of improved vaccines for older adults against viral diseases with highest burdens at old age, by promoting vi...
2019-12-12 - 2024-12-31 | Financiado

e-shape: EuroGEO Showcases Applications Powered by Europe The E-SHAPE proposal is driven by the need to develop operational EO services with and for the users and to create a conducive environment w...
2019-05-03 - 2023-04-30 | Financiado

ERINHA-Advance: Advancing European Research Infrastcuture on Highly Pathogenic Agents BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN participó en un H2020: H2020-INFRADEV-2018-2020 One of the great challenges of the 21st century is to develop the capacity to prevent and react to outbreaks caused by highly pathogenic hum...
2018-11-20 - 2022-06-30 | Financiado

PEVIA: PAN EBOLA VACCINE INNOVATIVE APPROACH Sofia ref. 116088 BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN participó en un H2020: H2020-JTI-IMI2-2015-08-single-stage Ebola virus (EBOV), a member of Filoviridae family of viruses, is one of the most dangerous microorganisms in the world, causing severe hemo...
2017-05-31 - 2023-05-31 | Financiado

ZIKAlliance: A global alliance for Zika virus control and prevention BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN participó en un H2020: H2020-SC1-2016-2017 "ZIKAlliance is a multidisciplinary project with a global ""One Health"" approach, built: on a multi-centric network of clinical cohorts in...
2016-12-13 - 2021-09-30 | Financiado

EBOPATH: Evaluation of species specific ebolavirus pathophysiology in xenochimeric mice BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN tramitó un H2020: H2020-MSCA-IF-2015 Ebolaviruses comprise five virus species of which at least three are highly pathogenic for humans. Other mammalian species such as non-human...
2016-03-09 - 2018-10-31 | Financiado

ERINHA2: European Research Infrastructure on Highly Pathogenic Agents 2 BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN participó en un H2020: H2020-INFRADEV-2014-2015 ERINHA2 aims to complete the work carried out during the first preparatory phase (PP1) - ERINHA - in order to reach the financial, administr...
2015-10-08 - 2017-06-30 | Financiado

EVAg: European Virus Archive goes global BERNHARDNOCHTINSTITUT FUER TROPENMEDIZIN participó en un H2020: H2020-INFRAIA-2014-2015 The overall objective will be to create and mobilise an International network of high calibre centres around a strong European group of inst...
2015-10-02 - 2020-07-31 | Financiado

BNI